MicroPort MedBot
Shanghai maker of the Toumai surgical robot, listed in Hong Kong
- Intuitive places 468 da Vinci robots as upgrades to da Vinci 5 accelerate, and raises its margin outlook for a second time
Intuitive placed 468 da Vinci systems in the second quarter of 2026, up from 395 a year earlier, including 246 da Vinci 5 units, and revenue rose 19% to $2.89 billion, the company said on 16 July. It lifted its 2026 non-GAAP gross margin outlook to 68% to 69% of revenue, the second increase this year, while holding da Vinci procedure growth guidance at 13.5% to 15.5% and pointing to the midpoint.
Mentioned - MicroPort MedBot doubles revenue to RMB551 million as Toumai exports reach 73% of 2025 sales
Shanghai MicroPort MedBot said revenue rose 114.2% to RMB551.1 million in 2025, with overseas sales of RMB400.2 million accounting for 73% of the total. The Hong Kong-listed surgical robot maker cut its net loss by 60.7% to RMB254.1 million as cumulative orders for its Toumai laparoscopic robot reached about 220 units.
Subject - Intuitive passes $10 billion in revenue as da Vinci 5 takes half of its robot shipments, but guides procedure growth lower
Intuitive reported on January 22, 2026 that 2025 revenue rose about 21% to $10.06 billion as surgeons performed 3.153 million da Vinci procedures, and da Vinci 5 made up 870 of the 1,721 systems it placed. The company guided 2026 da Vinci procedure growth to 13% to 15%, down from about 18%, and put the tariff cost to its gross margin at about 1.2% of revenue.
Mentioned - Edge Medical lists in Hong Kong after retail demand of 1,092 times, betting its surgical robots on export markets
Shenzhen Edge Medical raised HK$1,198.7 million in a Hong Kong IPO priced at HK$43.24 a share and began trading on 8 January 2026, with the retail tranche 1,091.94 times subscribed. Its first annual results showed revenue up 184.8% to RMB455.7 million and 50 of 72 robots delivered in 2025 going overseas.
Mentioned